🔎 Trials Near Me

Gara Jalqabaatti › Luukemiya Limfoositiikii Keessummaa › Virginia › Arlington

Qorannoo klinikaalii Luukemiya Limfoositiikii Keessummaa Arlington, VA keessatti

Qorannoo 4 Luukemiya Limfoositiikii Keessummaa f Arlington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Namoota walitti qabaa jiraSadarkaa 3
  • Inova Schar Cancer Institute ( Site 0015), Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06136559

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Namoota walitti qabaa jiraSadarkaa 2
  • Virginia Cancer Specialists, PC, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07221500

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

Namoota walitti qabaa jiraSadarkaa 3
  • Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT07516093

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Namoota walitti qabaa jiraSadarkaa 3
  • Virginia Cancer Specialists - Fairfax /ID# 268155, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Elb-2026 · NCT06428019

Qorannoo Luukemiya Limfoositiikii Keessummaa magaalota biroo keessatti

Qorannoo biroo Arlington keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.